Osteoarthritis Trial, Recruiting (NCT06499038)

Osteoarthritis Trial, Recruiting NCT06499038 Sponsor: Helse Møre og Romsdal HF Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT06499038 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 65 and 80 years old at the time of surgery who have been diagnosed with primary hip osteoarthritis (hip joint wear and tear)
People who need a first-time total hip replacement surgery
People who are willing and able to attend scheduled follow-up appointments for physical check-ups and imaging scans after surgery

Who may not be able to join:

People who are unable to give informed consent to participate
People who need a revision hip replacement (a repeat or corrective surgery on a previously replaced hip)
People who have previously had bone-cutting or bone-fixing surgery on the thigh bone or hip socket
People who have a bone metabolism condition other than osteoporosis (confirm with trial site)
People who have inflammatory arthritis, such as rheumatoid arthritis
People with a BMI over 40, where their weight significantly affects their ability to carry out everyday activities
People who have an active or suspected infection
People who have or have had cancer
People who are unable to participate due to language barriers or psychosocial conditions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Frank-David Øhrn, MD, PhD, Møre og Romsdal Hospital Trust

Phone: 71120000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06499038

Sponsor: Helse Møre og Romsdal HF

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: 71120000

More information: https://clinicaltrials.gov/study/NCT06499038

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 65 and 80 years old at the time of surgery who have been diagnosed with primary hip osteoarthritis (hip joint wear and tear)
People who need a first-time total hip replacement surgery
People who are willing and able to attend scheduled follow-up appointments for physical check-ups and imaging scans after surgery

Who may not be able to join:

People who are unable to give informed consent to participate
People who need a revision hip replacement (a repeat or corrective surgery on a previously replaced hip)
People who have previously had bone-cutting or bone-fixing surgery on the thigh bone or hip socket
People who have a bone metabolism condition other than osteoporosis (confirm with trial site)
People who have inflammatory arthritis, such as rheumatoid arthritis
People with a BMI over 40, where their weight significantly affects their ability to carry out everyday activities
People who have an active or suspected infection
People who have or have had cancer
People who are unable to participate due to language barriers or psychosocial conditions

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Helse Møre og Romsdal HF

Registry

ClinicalTrials.gov

Start date

25 August 2024

Est. completion

1 June 2027

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Translation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov